Focal adhesion kinase
From Proteopedia
(Difference between revisions)
(10 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <StructureSection load='2jkk' size='350' side='right' scene='' caption='Focal adhesion kinase 1 kinase domain complex with pyrimidine derivative inhibitor and sulfate (PDB code [[2jkk]]) '> | + | <StructureSection load='2jkk' size='350' side='right' scene='48/480805/Cv/1' caption='Focal adhesion kinase 1 kinase domain complex with pyrimidine derivative inhibitor and sulfate (PDB code [[2jkk]]) '> |
+ | == Function == | ||
- | For details on '''focal adhesion kinase or protein tyrosine kinase 2β (PTK2)''' see [[Molecular Playground/FAK]]<ref>PMID: | + | '''Focal adhesion kinase''' (FAK) is involved in cellular adhesion. During apoptosis, FAK is cleaved into 2 fragments. The smaller fragment is associated with death signaling. For details on '''focal adhesion kinase or protein tyrosine kinase 2β (PTK2)''' see [[Molecular Playground/FAK]]<ref>PMID:15688067</ref>. |
- | + | ||
- | + | ||
- | + | == Relevance == | |
- | + | ||
- | + | FAK is overexpressed in many tumor cells. Hence they are investigated as anti-tumor drug targets<ref>PMID:22075057</ref>. | |
- | + | == Structural insights == | |
- | + | FAK ATP-binding site is the <scene name='48/480805/Cv/5'>location of inhibitor binding</scene><ref>PMID:19030106</ref>. | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | == 3D Structures of focal adhesion kinase == | |
+ | [[Focal adhesion kinase 3D structures]] | ||
- | + | </StructureSection> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | *Focal adhesion kinase 2 (FAK2) See Pyk2 in [[Tyrosine kinase]] | ||
- | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Current revision
|
References
- ↑ Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68. PMID:15688067 doi:http://dx.doi.org/10.1038/nrm1549
- ↑ Cabrita MA, Jones LM, Quizi JL, Sabourin LA, McKay BC, Addison CL. Focal adhesion kinase inhibitors are potent anti-angiogenic agents. Mol Oncol. 2011 Dec;5(6):517-26. doi: 10.1016/j.molonc.2011.10.004. Epub 2011 Oct, 20. PMID:22075057 doi:http://dx.doi.org/10.1016/j.molonc.2011.10.004
- ↑ Lietha D, Eck MJ. Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation. PLoS ONE. 2008;3(11):e3800. Epub 2008 Nov 24. PMID:19030106 doi:10.1371/journal.pone.0003800